We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
+11.71%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$7.51B
AUM Growth
+$668M
(+9.8%)
Cap. Flow
+$14M
Cap. Flow
% of AUM
0.19%
Top 10 Holdings %
Top 10 Hldgs %
34.2%
Holding
1,319
New
77
Increased
462
Reduced
700
Closed
61
Avg Time Held
9.4
quarters
Top 10 Avg Time Held
9.9
quarters
Top 20 Avg Time Held
7.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$45.1M |
| 2 |
Home Depot
HD
|
+$13.5M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$10.9M |
| 4 |
Salesforce
CRM
|
+$10.2M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$10.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$9.39M |
| 2 |
Coca-Cola
KO
|
+$9.33M |
| 3 |
United Parcel Service
UPS
|
+$8.35M |
| 4 |
IBM
IBM
|
+$7.74M |
| 5 |
Union Pacific
UNP
|
+$6.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.15% |
| 2 | Consumer Discretionary | 12.55% |
| 3 | Healthcare | 12.54% |
| 4 | Financials | 10.24% |
| 5 | Communication Services | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1251
FuboTV Inc
FUBO
$267M
| $24.5K | ﹤0.01% |
981
+91
| +10% | +$1.74K |
2022 Q3
3 quarters
|
|
1252
Gevo
GEVO
$326M
| $20.4K | ﹤0.01% |
13,431
+2,154
| +19% | +$2.78K |
2022 Q2
4 quarters
|
|
|
CANO
1253
DELISTED
Cano Health, Inc.
CANO
| $18.6K | ﹤0.01% |
+134
| New | +$17.2K |
2023 Q2
0 quarters
|
|
|
NVTA
1254
DELISTED
Invitae Corporation
NVTA
| $17.3K | ﹤0.01% |
15,323
+1,417
| +10% | +$1.79K |
2022 Q2
4 quarters
|
|
|
PTRA
1255
DELISTED
Proterra Inc. Common Stock
PTRA
| $15.3K | ﹤0.01% |
12,755
| – | – |
2022 Q2
4 quarters
|
|
|
AMRS
1256
DELISTED
Amyris Inc.
AMRS
| $13K | ﹤0.01% |
12,604
+1,203
| +11% | +$1.12K |
2022 Q2
4 quarters
|
|
1257
AbCellera Biologics
ABCL
$4.06B
| – | – |
-12,000
| Closed | -$90.5K | – |
|
1258
BlackLine
BL
$1.73B
| – | – |
-3,200
| Closed | -$215K | – |
|
1259
Blend Labs
BLND
$236M
| – | – |
-10,780
| Closed | -$10.7K | – |
|
1260
Bionano Genomics
BNGO
$17M
| – | – |
-28
| Closed | -$18.9K | – |
|
1261
Bank of Hawaii
BOH
$2.64B
| – | – |
-5,249
| Closed | -$273K | – |
|
1262
CCC Intelligent Solutions
CCC
$4.13B
| – | – |
-12,248
| Closed | -$110K | – |
|
1263
Cenntro
CENN
$9.11M
| – | – |
-17
| Closed | -$4.81K | – |
|
1264
Certara
CERT
$1.39B
| – | – |
-11,569
| Closed | -$279K | – |
|
1265
Clover Health Investments
CLOV
$2.54B
| – | – |
-22,047
| Closed | -$18.6K | – |
|
1266
Carvana
CVNA
$45.9B
| – | – |
-66,950
| Closed | -$131K | – |
|
1267
Dell
DELL
$373B
| – | – |
-12,086
| Closed | -$486K | – |
|
1268
Erie Indemnity
ERIE
$11.6B
| – | – |
-2,774
| Closed | -$643K | – |
|
1269
Freshpet
FRPT
$3.08B
| – | – |
-4,135
| Closed | -$274K | – |
|
1270
Fulton Financial
FULT
$4.22B
| – | – |
-25,865
| Closed | -$357K | – |
|
1271
GlobalFoundries
GFS
$26.9B
| – | – |
-3,599
| Closed | -$260K | – |
|
1272
iShares Core MSCI International Developed Markets ETF
IDEV
$32.1B
| – | – |
-11,260
| Closed | -$681K | – |
|
1273
Inovio Pharmaceuticals
INO
$119M
| – | – |
-1,178
| Closed | -$11.6K | – |
|
1274
iRhythm Holdings
IRTC
$3.52B
| – | – |
-1,757
| Closed | -$218K | – |
|
1275
Madison Square Garden
MSGS
$9.69B
| – | – |
-1,575
| Closed | -$307K | – |
|
Similar funds
PCM
LPC
MFG
PAM
BS
BBVA
NMO
PAS
Xponance's Q2 2023 Portfolio in Review
As of Q2 2023, Xponance held 1,319 positions worth $7.51B, up 9.8% from $6.84B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Xponance's Q2 2023 filing shows 77 new, 462 increased, 700 reduced and 61 closed positions. Its largest new stake was Coupang: 152,372 shares worth $2.65M. The largest sale was Procter & Gamble, an estimated $9.39M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Xponance's largest Q2 2023 buy was Coupang: 152,372 shares worth $2.65M.
- Xponance added most to Meta Platforms (Facebook) in Q2 2023, an estimated $45.1M increase.
- Xponance's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $9.39M.
- Xponance fully exited iShares Core MSCI International Developed Markets ETF in Q2 2023, selling an estimated $681K.
- Xponance's ten largest holdings make up 34% of its $7.51B portfolio in Q2 2023.
- Xponance opened 77 new positions and closed 61 in Q2 2023.
- Xponance's portfolio value rose 9.8% quarter-over-quarter to $7.51B.
Based on Xponance's 13F filing for Q2 2023, filed 14 Jul 2023.